Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for pharmaceutical industry professionals · Tuesday, April 16, 2024 · 704,074,288 Articles · 3+ Million Readers

Single Cell Multiomics Market Size Demand for its End-Products to Increase at a Higher Rate in Developing Countries |AMR

Single cell multiomics market report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics.

PORTLAND, OREGON, UNITED STATES, October 5, 2022 /EINPresswire.com/ -- Single Cell Multiomics Market was pegged at $2.45 billion in 2020, and is expected to reach $13.90 billion by 2030, growing at a CAGR of 19.0% from 2021 to 2030. Rise in adoption of personalized medicine for the screening and diagnostics of genetic disorders and technological advancements in single-cell analysis products drive the growth of the global single cell multiomics market. However, dearth of skilled professionals and high cost of single-cell analysis products hinder the market growth. On the contrary, rise in funding in the research of single cell multiomics is expected to open lucrative opportunities for the market players in the future.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

The global single cell multiomics market includes an in-depth analysis of the prime market players such as BGI Genomics Co. Ltd., Bio-Rad Laboratories (Celsee, Inc.), Fluidigm Corporation, Cytiva Life Science (Previously GE), 10x Genomics, Illumina, Inc., MissionBio, NanoString Technologies, QIAGEN N.V., and Takara Bio.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/12148

𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:

• The Covid-19 pandemic disrupted workflows in the healthcare sector across the world. The outbreak forced several industries to shut down temporarily including sub-domains of healthcare services including single cell multiomics.
• However, the rise in chronic diseases and infectious diseases such as Covid-19 increased the demand for single cell multiomics. Moreover, it could be used to study human immune response to Covid-19 infection.
• Researchers uncovered several evidences of coordinated immune response to Covid-19 progress and various cellular components that could be used in developing targeted therapeutic interventions.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/12148

Based on type, the single cell genomics segment held the largest share in 2020, accounting for more than two-fifths of the market. However, the single cell proteomics segment is expected to manifest the highest CAGR of 19.9% from 2021 to 2030.

On the basis of application, the oncology segment dominated the market in terms of revenue in 2020, contributing to more than one-third of the market. However, the neurology segment is expected to register the highest CAGR of 19.7% during the forecast period.

The global single cell multiomics market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the largest share in 2020, accounting for nearly half of the market. However, the market across Europe is expected to register the highest CAGR of 22.8% during the forecast period.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Computational Biology Market

Electronic Health Records Market

𝐀𝐥𝐬𝐨 𝐑𝐞𝐚𝐝 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐁𝐥𝐨𝐠:

Singapore Biopharmaceuticals Market -- https://singaporehealthcarenews.blogspot.com/2022/10/biopharmaceuticals-market-revenue.html

Singapore Ulcerative Colitis Market -- https://singaporehealthcarenews.blogspot.com/2022/09/singapore-ulcerative-colitis-market.html

𝐀𝐕𝐄𝐍𝐔𝐄- 𝐀 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐁𝐚𝐬𝐞𝐝 𝐋𝐢𝐛𝐫𝐚𝐫𝐲 (𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐨𝐧-𝐝𝐞𝐦𝐚𝐧𝐝, 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐛𝐚𝐬𝐞𝐝 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 𝐦𝐨𝐝𝐞𝐥) 𝐎𝐟𝐟𝐞𝐫𝐞𝐝 𝐛𝐲 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

𝐆𝐞𝐭 𝐚𝐧 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐥𝐢𝐛𝐫𝐚𝐫𝐲 𝐨𝐟 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 𝐚𝐭 𝐚𝐧𝐲 𝐭𝐢𝐦𝐞 𝐟𝐫𝐨𝐦 𝐚𝐧𝐲 𝐝𝐞𝐯𝐢𝐜𝐞 𝐚𝐧𝐝 𝐚𝐧𝐲𝐰𝐡𝐞𝐫𝐞. 𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐬, 𝐟𝐨𝐥𝐥𝐨𝐰 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤: https://www.alliedmarketresearch.com/library-access

𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release